JR11 - Round table - Johannes DORST

JR11 - Round table - Johannes DORST

by Johannes Dorst

Life & Natural Systems Literature & Writing DNPReportage, journalism or collected columnsDNPBInterviews
🎙 Johannes Dorst 👥 1K 📅 January 28, 2026 ⏱ 19 min 👁 12 📄 original study 🧭 2026-08-16
Available in: English (current) Français

Keywords

ALSpresymptomaticgene mutation carriersbody compositionenergy expenditure

Summary

Johannes Dorst presents findings from the LUMINA study, a longitudinal cohort of presymptomatic ALS gene mutation carriers and non-carriers from the same families. The study, initiated in 2013, includes comprehensive assessments including metabolic testing, imaging, and neuropsychology. Cross-sectional data from 65 carriers and 73 non-carriers were analyzed for cardiovascular risk factors and body composition. Results show that SOD1 carriers have a ‘bad’ cardiovascular risk profile (high BMI, high glucose, low HDL), while C9orf72 carriers show the opposite. Bioimpedance analysis revealed significant alterations in carriers: reduced lean body mass, body cell mass, phase angle, and increased extracellular mass to body cell mass ratio, indicating fewer metabolically active cells. These changes are more pronounced in C9orf72 carriers, who also lose fat mass, whereas SOD1 carriers preserve or even increase fat mass. Resting energy expenditure is reduced in carriers, contrary to the hypermetabolism seen in symptomatic ALS, but increases as they approach expected onset. The findings suggest that reduced physical activity or compensatory mechanisms may underlie these alterations. The speaker also notes that similar patterns were observed in a US cohort with more aggressive SOD1 mutations, suggesting a genotype-specific effect.

187 words

Critical Evaluation

Value of the Information & Strength of the Argument

The presentation provides valuable insights into the presymptomatic phase of ALS, highlighting metabolic and body composition alterations that could serve as early biomarkers. The argumentation is logical and well-structured, with clear explanations of the methodology (bioimpedance analysis) and interpretation of results. The speaker acknowledges limitations, such as the cross-sectional nature and the speculative explanations for observed differences. The comparison between SOD1 and C9orf72 carriers adds depth, and the mention of unpublished collaborative data strengthens the credibility.

Scientific Rigor, Source Quality, Title Accuracy

The presentation is scientifically rigorous, with detailed methodology and reference to previous publications. The speaker cites a study by Angela Rosenbohm on physical activity reduction before onset, supporting the hypothesis that reduced activity may explain the findings. The title accurately reflects the content, which is a focused talk on presymptomatic metabolic alterations. No external sources are cited in the description, but the study itself is based on original data.

160 words

Title / Content Match

The title accurately reflects the content: a round table presentation on presymptomatic ALS gene mutation carriers.

Quality & Reliability

8/10

Presentation of original research data from a longitudinal cohort study, with detailed methodology and comparison with previous findings. The speaker is an expert in the field, and the study appears well-designed with appropriate controls. However, the data are preliminary and not yet fully published, and some interpretations are speculative.

Key Moments

Markers derived by PSI from the transcript: the creator did not define chapters.

Cited Sources

  • LUMINA study (not specified) — The longitudinal study of unaffected family members of ALS patients, presented by the speaker.

Concurring Sources

  • Rosenbohm et al. (2018) — Study showing reduced physical activity years before ALS onset, cited by the speaker as a possible explanation for the findings.

Contribution & Novelties

This presentation offers novel insights into the presymptomatic phase of ALS, revealing specific metabolic and body composition alterations that differ between SOD1 and C9orf72 mutation carriers. The finding of reduced metabolically active cells and hypometabolism in presymptomatic carriers, contrasting with hypermetabolism in symptomatic ALS, suggests a dynamic metabolic shift that could be targeted for early intervention. The study also highlights the potential of bioimpedance parameters as early biomarkers.

Pour aller plus loin :

103 words

Radar Profile

The radar profile shows high scores in information quantity, quality, and reliability, with a slightly lower technical level. This indicates a well-substantiated presentation with strong scientific content, though some technical aspects may be complex for a general audience.

Reliability 8/10